Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001199835-09-000393
Filing Date
2009-07-15
Accepted
2009-07-15 15:17:21
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 METABOLIC RESEARCH, INC. 10-K/A FIRST AMENDMENT metabolic_research-10ka1.htm 10-K/A 941606
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) AND RULE 15D exhibit_31-1.htm EX-31.1 21334
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) AND RULE 15D exhibit_31-2.htm EX-31.2 21304
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF SARBANES-OXL exhibit_32-1.htm EX-32.1 11894
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF SARBANES-OXL exhibit_32-2.htm EX-32.2 11647
6 filename6.htm CORRESP 22078
  Complete submission text file 0001199835-09-000393.txt   1031664
Mailing Address 6320 MCLEOD DRIVE SUITE 7 LAS VEGAS NV 89120
Business Address 6320 MCLEOD DRIVE SUITE 7 LAS VEGAS NV 89120 7022637070
Metabolic Research, Inc. (Filer) CIK: 0001081369 (see all company filings)

EIN.: 352065469 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-25879 | Film No.: 09945879
SIC: 2834 Pharmaceutical Preparations